Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alliance Pharma delays preliminary results

(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday. The AIM-traded firm said the results, initially scheduled for 23 April, would now be delayed until early May.

It said it expected to provide an update on the publication date by 26 April.

Following an earlier announcement on 5 April, Alliance Pharma informed shareholders that despite the advanced stage of the audit process, its auditor, Deloitte LLP, had requested more time to finalise their work.

"Alliance reiterates that the details provided in the full year trading update on 29 January remain accurate," the board said in its statement.

At 1414 BST, shares in Alliance Pharma were down 1.63% at 36.25p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

RBC Capital lifts Centrica to 'outperform', shares rally
(Sharecast News) - RBC Capital Markets upgraded Centrica on Friday to 'outperform' from 'sector perform' and lifted the price target to 170p from 145p.
Jefferies reiterates 'buy' on National Grid, trims price target
(Sharecast News) - Jefferies trimmed its price target on National Grid on Friday as it reiterated its 'buy' rating on the energy infrastructure firm.
JPMorgan reiterates 'overweight' on Whitbread
(Sharecast News) - JPMorgan Cazenove reiterated its 'overweight' rating on Whitbread on Friday as it said it continues to be one of its key convictions, and sees the recent pullback - the shares are down 20% year-to-date - as "an opportunity to revisit the story".
Short-lived sunny spell helps boost UK supermarkets
(Sharecast News) - UK supermarket sales pushed higher in May, industry data showed on Friday, boosted by a brief spell of warmer weather.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.